Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Abbott secures FDA and CE Mark approvals for Amplatzer delivery system

The approval allows for the delivery system’s use alongside the Amplatzer Piccolo occluder.

Latest news

EDX Medical plans UK bowel cancer testing service launch

EDX’s test is mooted to become the most advanced colorectal cancer testing service ever offered in the UK.

Curasight doses first patient in Phase I brain cancer trial of uTREAT

The study is designed to assess uTREAT as a targeted radiopharmaceutical therapy in patients newly diagnosed with GBM.

MARAbio introduces MAR-Autism Test to detect maternal autoantibodies

Healthcare professionals in most regions of the US can order the test for women who previously had a child diagnosed with autism.

FDA clears SleepRes’ Kricket PAP device for obstructive sleep apnoea

The KPAP sleep therapy platform is developed to offer an adaptive and patient-focused alternative to traditional CPAP therapy.

FDA clears CMR Surgical’s Versius Plus robot

CMR Surgical’s Versius Plus robot’s clearance follows the FDA’s de novo classification of the company’s first-generation Versius robot in October 2024.